Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children
- PMID: 26518400
- DOI: 10.1016/j.vaccine.2015.10.076
Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children
Abstract
Background: In addition to antigens, vaccines contain small amounts of preservatives, adjuvants, and residual substances from the manufacturing process. Some parents have concerns about the safety of these ingredients, yet no large epidemiological studies have specifically examined associations between health outcomes and vaccine ingredients, other than thimerosal. This study examined the extent to which the Vaccine Safety Datalink (VSD) could be used to study vaccine ingredient safety in children.
Methods: Children born 2004-2011 were identified in VSD data. Using immunization records, two cohorts were identified: children who were up-to-date and children who were undervaccinated before age 2 years. A database was also created linking vaccine type and manufacturer with ingredient amounts documented in vaccine package inserts. Thirty-four ingredients in two or more infant vaccines were identified. However, only amounts (in mg) for aluminum were consistently documented and commonly contained in infant vaccines. Analyses compared vaccine aluminum exposure across cohorts and determined the statistical power for studying associations between aluminum exposure and hypothetical vaccine adverse events.
Results: Among 408,608 children, mean cumulative vaccine aluminum exposure increased from 1.11 to 4.00 mg between ages 92-730 days. Up-to-date children were exposed to 11-26% more aluminum from vaccines than undervaccinated children. Power analyses demonstrated that safety studies of aluminum could detect relative risks ranging from 1.1 to 5.8 for a range of adverse event incidence.
Conclusions: The safety of vaccine aluminum exposure can be feasibly studied in the VSD. However, possible biological mechanisms and confounding variables would need to be considered before conducting any studies.
Keywords: Aluminum; Immunizations.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.Vaccine. 2006 Jul 7;24(27-28):5627-36. doi: 10.1016/j.vaccine.2006.04.019. Epub 2006 May 2. Vaccine. 2006. PMID: 16740348 Clinical Trial.
-
[In process].Med Monatsschr Pharm. 2016 Oct;39(10):447-8. Med Monatsschr Pharm. 2016. PMID: 29979546 German. No abstract available.
-
Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age.Pediatr Infect Dis J. 2014 Dec;33(12):e320-9. doi: 10.1097/INF.0000000000000462. Pediatr Infect Dis J. 2014. PMID: 24978857 Clinical Trial.
-
[Aluminium adjuvant exposure through vaccines in France in 2018].Ann Pharm Fr. 2020 Mar;78(2):111-128. doi: 10.1016/j.pharma.2020.01.002. Epub 2020 Jan 17. Ann Pharm Fr. 2020. PMID: 32081303 Review. French.
-
Hypersensitivity reactions to vaccine constituents: a case series and review of the literature.Dermatitis. 2012 May-Jun;23(3):102-9. doi: 10.1097/DER.0b013e31825228cf. Dermatitis. 2012. PMID: 22653170 Review.
Cited by
-
Patterns of childhood immunization and all-cause mortality.Vaccine. 2017 Dec 4;35(48 Pt B):6643-6648. doi: 10.1016/j.vaccine.2017.10.034. Epub 2017 Oct 20. Vaccine. 2017. PMID: 29061349 Free PMC article.
-
Aluminium toxicosis: a review of toxic actions and effects.Interdiscip Toxicol. 2019 Oct;12(2):45-70. doi: 10.2478/intox-2019-0007. Epub 2020 Feb 20. Interdiscip Toxicol. 2019. PMID: 32206026 Free PMC article. Review.
-
Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months.Acad Pediatr. 2023 Jan-Feb;23(1):37-46. doi: 10.1016/j.acap.2022.08.006. Epub 2022 Sep 28. Acad Pediatr. 2023. PMID: 36180331 Free PMC article.
-
Inflammation and Autophagy: A Convergent Point between Autism Spectrum Disorder (ASD)-Related Genetic and Environmental Factors: Focus on Aluminum Adjuvants.Toxics. 2022 Aug 31;10(9):518. doi: 10.3390/toxics10090518. Toxics. 2022. PMID: 36136483 Free PMC article. Review.
-
Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule.Vaccine. 2019 Feb 28;37(10):1325-1331. doi: 10.1016/j.vaccine.2019.01.040. Epub 2019 Jan 29. Vaccine. 2019. PMID: 30709727 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical